Login / Signup

COMBACTE LAB-Net: building a European laboratory network for clinical trials on anti-infectives.

Tomislav KostyanevLeen TimbermontTuba VilkenChristine LammensSurbhi Malhotra-KumarYouri GlupczynskiHerman Goossens
Published in: Future microbiology (2021)
LAB-Net, the laboratory network of COMBACTE, has established itself as an indispensable network for clinical trials in infectious diseases that plays a crucial part across 30 clinical studies not only within, but also outside the COMBACTE consortium. Since its official launch in January 2013, LAB-Net has expanded more than threefold and in Q4 2020 it encompasses 841 labs across 41 countries in Europe. In addition, LAB-Net has crossed the European borders and collaborates with more than 300 laboratories spread across the globe. The tight collaboration with partners within COMBACTE and beyond contributed tremendously to the growth of LAB-Net over the years. A sustainable infrastructure beyond COMBACTE-NET is needed to ensure the smooth handover and continuity of the achievements made by the project.
Keyphrases
  • clinical trial
  • infectious diseases
  • randomized controlled trial
  • quality improvement
  • open label
  • hepatitis c virus
  • human immunodeficiency virus
  • double blind
  • phase iii
  • men who have sex with men